Liver Neoplasms  >>  Inlyta (axitinib)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Inlyta (axitinib) / Pfizer
NCT01210495 / 2010-021590-37: Axitinib For The Treatment Of Advanced Hepatocellular Carcinoma

Checkmark ESMO 2014
Sep 2014 - Sep 2014: ESMO 2014
Completed
2
224
Japan, US, Europe, RoW
Axitinib (AG-013736), Best Supportive Care, Placebo
Pfizer
Hepatocellular Carcinoma
03/14
12/16

Download Options